Retinal Vasculitis: Clinical Trials

3 trials for Retinal Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Unknown 2, Completed 1

Follow Retinal Vasculitis: new trials by email Literature Review of Retinal Vasculitis trials Research Report on Retinal Vasculitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Six-months Versus Nine-months ATT for Ocular TB
Anti-Tuberculosis Treatment - Tuberculosis (TB), Uveitis
Phase 4CompletedL.V. Prasad Eye Institute582020-01-012024-09-26
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
H.P. ACTHAR GEL - Uveitis, Posterior, Vasculitis Retinal
Phase 4UnknownOcular Immunology and Uveitis Foundation402017-03-222019-09-12
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
methylorednisolone, dextrose water 5% - Behcet's Disease
Phase 4UnknownTehran University of Medical Sciences342010-02-012011-03-02

Narrower conditions

Uveitis, Posterior (2)  ·  Behcet Syndrome (1)  ·  Choroiditis (1)  ·  Tuberculosis (1)  ·  Uveitis (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Eye Diseases (3)  ·  Panuveitis (3)  ·  Retinal Diseases (3)  ·  Uveal Diseases (3)  ·  Vascular Diseases (3)  ·  Vasculitis (3)  ·  Uveitis (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Choroid Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Gram-Positive Bacterial Infections (1)

Sponsors

L.V. Prasad Eye Institute (1)  ·  Ocular Immunology and Uveitis Foundation (1)  ·  Tehran University of Medical Sciences (1)

Countries

Burma (1)  ·  India (1)  ·  Iran (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Farhad Shahram, Professor (1)